Detalles de la búsqueda
1.
Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019-2020 A(H1N1)pdm09 predominant influenza season in Israel.
J Med Virol
; 95(2): e28498, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653733
2.
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
J Infect Dis
; 225(5): 785-792, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850049
3.
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.
Euro Surveill
; 27(30)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904058
4.
The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems.
Euro Surveill
; 27(16)2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35451365
5.
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
J Infect Dis
; 224(4): 616-619, 2021 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34398244
6.
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
Euro Surveill
; 26(26)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212838
7.
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021.
Euro Surveill
; 26(45)2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34763751
8.
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
N Engl J Med
; 386(5): 492-494, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965337
9.
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
N Engl J Med
; 386(14): 1377-1380, 2022 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35297591
10.
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
N Engl J Med
; 384(25): 2453-2454, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826815
11.
Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients.
J Heart Lung Transplant
; 2024 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38522765
12.
Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter Season.
Vaccines (Basel)
; 11(10)2023 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897026
13.
Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic.
Front Microbiol
; 14: 1296179, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322758
14.
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients.
Viruses
; 15(1)2023 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680292
15.
Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation.
J Heart Lung Transplant
; 41(9): 1210-1213, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794051
16.
Human metapneumovirus prevalence during 2019-2021 in Israel is influenced by the COVID-19 pandemic.
Int J Infect Dis
; 120: 205-209, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35472530
17.
Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic.
Front Microbiol
; 13: 902476, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35770154
18.
The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 - a double-blind, randomized placebo-controlled trial.
Int J Infect Dis
; 122: 733-740, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35811080
19.
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variant.
J Heart Lung Transplant
; 41(10): 1417-1425, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35710484
20.
Viral co-pathogens in COVID-19 acute respiratory syndrome - what did we learn from the first year of pandemic?
Int J Infect Dis
; 116: 226-229, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038602